CNS Lymphoma Team | Tampa General Hospital

CNS Lymphoma Team

As an academic medical center, Tampa General Hospital offers a collaborative approach to all patient care with experts representing multiple specialties. Our multidisciplinary team includes renowned hematology-oncology specialists, physician scientists, nurses, and physician assistants. Additionally, CNS Lymphoma patients work directly with a care navigator to answer any questions they may have and ensure their experience is as seamless as possible.

Medical Leadership

   

Eduardo Sotomayor, MD
Director
TGH Cancer Institute

Dr. Sotomayor is the director of the newly established Cancer Institute at Tampa General Hospital. He is a pioneer in the field of cancer immunology and immunotherapy and an internationally renowned expert in lymphoma research and treatment. Prior to joining Tampa General, he was the director of the George Washington University Cancer Center with responsibility and authority over all aspects of cancer care and research at GW and affiliated health systems. He was also a professor of medicine in the division of hematology/oncology at George Washington University School of Medicine and Health Sciences.

   

Tulika Ranjan, MD
Director, Neuro-Oncology
TGH Cancer Institute

Dr. Tulika Ranjan is a renowned neuro-oncologist with training and experience from the best comprehensive neuro-oncology programs in the world. She has a wealth of experience in treating adult primary brain and spinal cord tumors and has conducted groundbreaking research on new therapies for treating glioblastoma (GBM).

Prior to joining Tampa General Hospital, Dr. Ranjan was the director of the Allegheny Health Network (AHN) adult neuro-oncology program that specialized in advanced modalities such as laser interstitial thermal therapy and cancer stem cell chemo-sensitivity testing. She also served as chairperson for AHN Cancer Institute Neurologic-Oncology disease site leadership team.

View all medical journals published by Dr. Ranjan on PubMed Central®.

ivan borrello md

Ivan Borrello, MD
Director, Myeloma, BMT, and Cell Therapies
TGH Cancer Institute

Dr. Ivan M. Borrello is a hematologist oncologist and renowned physician-scientist who serves as Medical Director of the Myeloma, Bone Marrow Transplant (BMT) and Cell Therapies program within the TGH Cancer Institute. Fluent in English, Italian, Spanish and Portuguese, Dr. Borrello is recognized as a leader in the field of immunotherapy of hematologic malignancies (leukemias, lymphomas, multiple myeloma) as well as bone marrow and stem cell transplants. 

Providers

Alan Kerr MD headshot

Alan Kerr, MD
Hematology Oncology

Dr. D. Alan Kerr is a hematologist-oncologist and physician scientist with Tampa General Hospital, where he previously conducted continuity clinic work with a focus on malignant hematology. He specializes in malignant hematology.

Prior to joining Tampa General, Dr. Kerr treated patients in a private community practice at Advanced Cancer Treatment Centers (ACTC) in Brooksville, Fla., after completing a three-year hematology and medical oncology fellowship program with Moffitt Cancer Center/University of South Florida. Before that, he completed an internal medicine residency program at the University of Louisville in Kentucky, where he served as a chief medical resident. In the same department, he followed his passion for teaching future medical professionals as an assistant professor from 2015 to 2016. Dr. Kerr received his medical degree from the University of Louisville School of Medicine and holds a PhD in biochemistry and molecular biology from the University of Louisville.

Dr. Kerr is a site investigator for numerous active clinical trials, and his primary clinical interests is lymphomas. Well-versed in translational research and clinical research protocols, Dr. Kerr is credited with several publications, oral presentations and abstracts on a wide range of oncology topics. He is a diplomate of the American Board of Internal Medicine and a member of the American Society of Clinical Oncology and the American Society of Hematology.

 Nikesh Shah MD headshot

Nikesh Shah, MD
Hematology Oncology

Dr. Nikesh Shah is a hematologist-oncologist at Tampa General Hospital who specializes in hematologic malignancies, including aggressive lymphomas and acute lymphoblastic leukemia (ALL). Prior to joining Tampa General, Dr. Shah served as a chief fellow for the hematology/oncology fellowship program at Moffitt Cancer Center and the University of South Florida in Tampa. He completed the J. Willis Hurst Internal Medicine Residency Program at Emory University School of Medicine in Atlanta after receiving his medical degree from the University of Miami Leonard M. Miller School of Medicine in Coral Gables, Fla.

Dr. Shah is dedicated to developing close relationships with his patients and their families, providing them with a full understanding of each disease and determining the best personalized care for each patient. To accomplish that, Dr. Shah enjoys conducting clinical research to identify the most cutting-edge treatment options available and has been credited with several peer-reviewed publications, presentations, abstracts and book chapters in areas of his expertise. He is also an internal medicine resident mentor and has provided professional insight as a speaker at multiple Lymphoma Clinical Congress sessions.

Dr. Shah has memberships with the American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research, Florida Society of Clinical Oncology and the Florida Medical Association. He speaks English and Gujarati.

Support Team

 

Brigett Brandjes, PA-C
Physician Assistant

jessica neil headshot

Jessica Neil, APP
Physician Assistant

 samantha roberts headshot

Samantha Roberts, MSN, APRN, FNP-BC
Nurse Practitioner

 Waleska Gonzalez headshot

Waleska Gonzalez
Neuro-Oncology Coordinator

Phone: (813) 844-5047

 Laura Kate Miller headshot

Laura Kate Miller
Neuro-Oncology Navigator

Phone: (813) 844-3463